Royalty Pharma plcRPRXNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank52
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P52
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -4.48% |
| Q3 2025 | 612.01% |
| Q2 2025 | -82.89% |
| Q1 2025 | 17.02% |
| Q4 2024 | -61.48% |
| Q3 2024 | 430.43% |
| Q2 2024 | 2200.00% |
| Q1 2024 | -99.32% |
| Q4 2023 | 604.76% |
| Q3 2023 | -58.82% |
| Q2 2023 | -32.89% |
| Q1 2023 | 151.70% |
| Q4 2022 | -426.67% |
| Q3 2022 | -53.61% |
| Q2 2022 | 708.33% |
| Q1 2022 | 538.30% |
| Q4 2021 | -94.47% |
| Q3 2021 | -78.75% |
| Q2 2021 | 471.43% |
| Q1 2021 | 135.00% |
| Q4 2020 | -201.27% |
| Q3 2020 | 777.78% |
| Q2 2020 | -55.00% |
| Q1 2020 | -72.97% |
| Q4 2019 | -35.65% |
| Q3 2019 | 167.44% |
| Q2 2019 | -58.65% |
| Q1 2019 | 0.00% |